Suivre
Nemanja Djokovic
Nemanja Djokovic
Faculty of Pharmacy, University of Belgrade
Adresse e-mail validée de pharmacy.bg.ac.rs
Titre
Citée par
Citée par
Année
In silico methods for design of kinase inhibitors as anticancer drugs
Z Gagic, D Ruzic, N Djokovic, T Djikic, K Nikolic
Frontiers in chemistry 7, 873, 2020
402020
Modulating Protein–Protein Interactions with Visible‐Light‐Responsive Peptide Backbone Photoswitches
L Albert, A Peñalver, N Djokovic, L Werel, M Hoffarth, D Ruzic, J Xu, ...
ChemBioChem 20 (11), 1417-1429, 2019
222019
Structure-based design of selective histone deacetylase 6 zinc binding groups
LA Alves Avelar, D Ruzic, N Djokovic, T Kurz, K Nikolic
Journal of Biomolecular Structure and Dynamics 38 (11), 3166-3177, 2020
72020
The oxidoreductase PYROXD1 uses NAD (P)+ as an antioxidant to sustain tRNA ligase activity in pre-tRNA splicing and unfolded protein response
I Asanović, E Strandback, A Kroupova, D Pasajlic, A Meinhart, ...
Molecular Cell 81 (12), 2520-2532. e16, 2021
52021
Synthesis, in silico, and in vitro studies of novel dopamine D2 and D3 receptor ligands
M Elek, N Djokovic, A Frank, S Oljacic, A Zivkovic, K Nikolic, H Stark
Archiv der Pharmazie 354 (6), 2000486, 2021
52021
Synthesis and biological activity of a cytostatic inhibitor of MLLr leukemia targeting the DOT1L protein
C Bon, Y Si, M Pernak, M Barbachowska, E Levi-Acobas, V Cadet Daniel, ...
Molecules 26 (17), 5300, 2021
52021
An Integrative in silico Drug Repurposing Approach for Identification of Potential Inhibitors of SARS‐CoV‐2 Main Protease
N Djokovic, D Ruzic, T Djikic, S Cvijic, J Ignjatovic, S Ibric, K Baralic, ...
Molecular Informatics 40 (5), 2000187, 2021
12021
Medicinal chemistry of histone deacetylase inhibitors
D Ružić, N Đoković, K Nikolić, Z Vujić
Arhiv za farmaciju 71 (2), 73-100, 2021
12021
Fragment-Based Drug Design of Selective HDAC6 Inhibitors
D Ruzic, N Djokovic, K Nikolic
Protein-Ligand Interactions and Drug Design, 155-170, 2021
12021
Expanding the Accessible Chemical Space of SIRT2 Inhibitors through Exploration of Binding Pocket Dynamics
N Djokovic, D Ruzic, M Rahnasto-Rilla, T Srdic-Rajic, ...
Journal of Chemical Information and Modeling, 2022
2022
Quinazoline-based analog of adenine as an antidote against MLL-rearranged leukemia cells: synthesis, inhibition assays and docking studies
C Bon, M Barbachowska, N Djokovic, D Ruzic, Y Si, L Soresinetti, C Jallet, ...
Future Medicinal Chemistry 14 (8), 557-570, 2022
2022
Discovery of 1-benzhydryl piperazine-based HDAC inhibitors with anticancer and antimetastatic properties against human breast cancer: synthesis, molecular modeling, in vitro …
D Ruzic, M Petkovic, N Djokovic, J Santibanez, B Ellinger, M Beljkas, ...
2022
Bistable Photoswitch Allows in Vivo Control of Hematopoiesis
L Albert, J Nagpal, W Steinchen, L Zhang, L Werel, N Djokovic, D Ruzic, ...
ACS Central Science, 2021
2021
Medicinska hemija inhibitora histon deacetilaza
D Ružić, N Đoković, K Nikolić, Z Vujić
Arhiv za farmaciju 71 (2), 73-100, 2021
2021
Front Cover: Modulating Proteinâ Protein Interactions with Visibleâ Lightâ Responsive Peptide Backbone Photoswitches (ChemBioChem 11/2019)
L Albert, A Peñalver, N Djokovic, L Werel, M Hoffarth, D Ruzic, J Xu, ...
Wiley Periodicals, Inc., 2019
2019
Front Cover: Modulating Protein–Protein Interactions with Visible‐Light‐Responsive Peptide Backbone Photoswitches (ChemBioChem 11/2019)
L Albert, A Peñalver, N Djokovic, L Werel, M Hoffarth, D Ruzic, J Xu, ...
ChemBioChem 20 (11), 1326-1326, 2019
2019
The Oxidoreductase PYROXD1 Utilizes NAD (P)+ As an Antioxidant to Sustain tRNA Ligase Activity in Pre-tRNA Splicing and Unfolded Protein Response
I Asanovic, E Strandback, A Kroupova, D Pasajlic, A Meinhart, ...
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–17